| Tap a line for its trend | Last 12Mto Sep 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 144.98× | 144.98× | 136.51× | — | 112.15× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 0.35× | 0.35× | 0.37× | 0.41× | 0.39× | ||
| −0.71× | −0.71× | 0.16× | −1.02× | −2.20× | ||
| −0.19× | −0.19× | 0.06× | −0.45× | −0.98× |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/09/2026 | |
|---|---|---|---|---|---|---|
| Receivable Days (DSO) | 112.15 | — | 136.51 | 144.98 | 144.98 | |
| Asset Turnover | 0.39 | 0.41 | 0.37 | 0.35 | 0.35 | |
| Cash Conversion (CFO/Net Income) | -2.20 | -1.02 | 0.16 | -0.71 | -0.71 | |
| CFO/EBITDA | -0.98 | -0.45 | 0.06 | -0.19 | -0.19 |